logo
PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid's D-PLEX100 Approaches Critical Phase 3 Data Readout

PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid's D-PLEX100 Approaches Critical Phase 3 Data Readout

Yahoo2 days ago

New report from PESG Research brand covers PolyPid*, which is tackleing the $10 billion dollar a year surgeical site infections cost with its innovative PLEX technology
New York, May 30, 2025 (GLOBE NEWSWIRE) -- PESG Research is releasing a report today examining PolyPid Ltd.*, an innovative late-stage biopharmaceutical company developing revolutionary localized drug delivery technologies for surgical infection prevention. The below report explores the company's breakthrough PLEX platform technology, its upcoming topline phase 3 data, and potential implications for transforming surgical care practices in the multi-billion dollar surgical site infection prevention market.
This report contains sponsored content, please see refer to the disclaimers and disclosures included at the end of this report.
Executive Summary
The surgical site infection (SSI) prevention landscape stands at a potential inflection point as PolyPid Ltd. prepares to announce topline results from its pivotal SHIELD II Phase 3 trial by the end of Q2 2025. The company's D-PLEX100 represents a paradigm shift in infection prevention, utilizing novel polymer-lipid encapsulation matrix (PLEX) technology to deliver sustained antibiotic release directly at surgical sites for 30 days. With SSIs affecting up to 30% of colorectal surgeries and imposing substantial healthcare costs estimated at $10 billion annually in the US and EU, successful development of D-PLEX100 could address a critical unmet medical need. The FDA's assignment of Breakthrough Therapy, Fast Track, and Qualified Infectious Disease Product (QIDP) designations underscores the regulatory recognition of this approach's potential significance.The Critical Challenge of Surgical Site Infections
Surgical site infections remain one of healthcare's most persistent challenges, representing 20% of all healthcare-associated infections in US hospitals. Despite advances in surgical techniques and prophylactic protocols, SSI rates in high-risk procedures like colorectal surgery can reach 30%, leading to extended hospital stays of 7-11 additional days and mortality risk increases of 2-11 fold. The economic burden is staggering, with direct costs averaging $11,000-26,000 per infection and total annual costs reaching approximately $10 billion in the US alone.
Current prevention strategies rely primarily on systemic antibiotic prophylaxis administered intravenously 30-60 minutes before surgery. However, this approach faces fundamental limitations. Surgical incisions disrupt local blood flow, significantly limiting antibiotic penetration to the precise site where infections occur. Moreover, systemic administration exposes patients to higher drug concentrations throughout the body, potentially increasing toxicity risks and contributing to antimicrobial resistance development.
PLEX Technology: A Novel Approach to Localized Drug Delivery
PolyPid's proprietary PLEX technology represents a sophisticated advancement in controlled drug delivery systems. The platform creates thousands of alternating layers of biocompatible polymers and lipids that physically embed active pharmaceutical ingredients. As these outer layers gradually disintegrate upon exposure to body fluids, they enable precise, predetermined drug release rates spanning several days to months.
For D-PLEX100, this technology pairs with doxycycline, a broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic-resistant strains. The formulation achieves local antibiotic concentrations 10-115 times higher than systemic administration while using only a fraction of the total drug amount, potentially minimizing systemic exposure and associated side effects.
Clinical Development Progress and Regulatory Recognition
The clinical development program for D-PLEX100 has demonstrated encouraging signals across multiple surgical contexts. In Phase 2 abdominal surgery trials, D-PLEX100 plus standard of care achieved a statistically significant 59% reduction in the primary endpoint compared to standard of care alone (p=0.0086). Perhaps more notably, the treatment group experienced zero deaths compared to five in the control arm within 60 days post-surgery.
The pivotal SHIELD I Phase 3 trial, while not meeting its primary endpoint in the full intent-to-treat population, revealed compelling efficacy in a pre-specified subgroup analysis. Among patients with large surgical incisions (>20 cm), D-PLEX100 demonstrated a statistically significant 54% reduction in the composite primary endpoint of SSIs, reinterventions, and mortality (p=0.0032). This finding directly informed the design of the ongoing SHIELD II trial, which focuses specifically on this higher-risk patient population.The FDA's regulatory designations reflect recognition of D-PLEX100's potential significance. Breakthrough Therapy designation is reserved for drugs that demonstrate substantial improvement over existing treatments for serious conditions. Fast Track designation facilitates more frequent FDA communications and potentially accelerated review timelines. The QIDP designation provides additional market exclusivity incentives for addressing antimicrobial resistance challenges.
SHIELD II: A Potentially Definitive Study
The ongoing SHIELD II Phase 3 trial represents a carefully designed study incorporating lessons learned from SHIELD I. Following an independent Data Safety Monitoring Board's review of unblinded efficacy data from the first 430 enrolled patients, the board recommended concluding the study at 800 patients—the lowest sample size reassessment option available. This recommendation, while requiring additional enrollment beyond the initially planned 624 patients, may suggest positive efficacy trends in the analyzed interim data.
The study's multinational design spans approximately 60 centers across the United States, Europe, and Israel, enhancing the generalizability of results across different healthcare settings and patient populations. The primary endpoint focuses on a composite of SSI events, reinterventions, and mortality within 30 days post-surgery, as adjudicated by an independent committee.
Broader Industry ImplicationsSuccess of D-PLEX100 could catalyze broader adoption of localized drug delivery approaches in surgical settings. The technology's platform nature suggests potential applications beyond infection prevention, including localized chemotherapy delivery through the company's OncoPLEX program, currently in preclinical development for solid tumor treatment.
The substantial market opportunity—with approximately 12 million eligible procedures annually in the US and 8 million in Europe—underscores the potential healthcare impact. PolyPid has already secured European commercialization rights through a partnership with Advanz Pharma, valued at up to $115 million plus royalties, while advancing discussions for US market partnerships.
Conclusion
As the pharmaceutical industry grapples with antimicrobial resistance and healthcare systems seek cost-effective solutions to persistent clinical challenges, D-PLEX100's approaching data readout represents a potentially significant milestone. The convergence of compelling preclinical and early clinical data, regulatory recognition, and substantial unmet medical need positions this development as one to monitor closely in the evolving landscape of surgical infection prevention.Recent News Highlight from PolyPid: PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections >> Click here to Subscribe for more updates like this or go to https://www.pesgresearch.com/subscribe * Legal Disclaimer & Disclosure: Nothing in this report constitutes medical, financial or any form professional or licensedadvice. This report is published by 'PESG Research', a digital promotional content brand who's operators are compensated to provide digestable and favorabel coverage of companies. This report contains and is a form of paid promotional content or advertising for PolyPid Ltd and was produced as part of the fee's they pay PESG's operators, Arx Advisory Ltd. This report has not been reviewed or approved by PolyPId prior to publication and it does not represent an official communication from PolyPid. The operators of PESG Research received or are expected to receive a monthly recurring fee of five thousand united states dollars via wire transfer from PolyPid as part of an ongoing agreement starting May 1, 2025 in return for distribution and promotional coverage services, and receive additional monthly compensation for non promotional unrelated data and advisory services on top of that. Please review the full disclaimers and compensation disclosures here for further details: redditwire.com/terms. Readers are advised to refer to the official materials of the company aforementioned. The report should not be treated as objective.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Poor Communication Costs the Tech Industry $50 Billion: ParallelStaff Launches Initiative to Bridge Global Gaps
Poor Communication Costs the Tech Industry $50 Billion: ParallelStaff Launches Initiative to Bridge Global Gaps

Yahoo

time35 minutes ago

  • Yahoo

Poor Communication Costs the Tech Industry $50 Billion: ParallelStaff Launches Initiative to Bridge Global Gaps

DALLAS, TX, June 11, 2025 (GLOBE NEWSWIRE) -- ParallelStaff, a Dallas-based nearshore outsourcing and technology services provider, has announced a new initiative to address one of the tech industry's most costly and overlooked challenges: communication failures in IT projects. With estimates suggesting that ineffective collaboration leads to more than $50 billion in annual losses, the company focuses on improving team alignment and project execution through strategic nearshore Studies have shown that 50% of IT projects fail due to breakdowns in communication, often rooted in unclear goals, inconsistent feedback, and misaligned stakeholder expectations. These issues are particularly pronounced in distributed and cross-border development environments. As software development outsourcing continues to grow, particularly among companies seeking speed and scalability, the ability to maintain effective communication has emerged as a mission-critical component of tech project management. 'Communication challenges are not just a soft-skill issue, they're a bottom-line problem,' said Miguel Hernandez, Vice President of Operations at ParallelStaff. 'Budget overruns, delayed releases, and even project abandonment are symptoms of deeper alignment issues. Our initiative is about restoring clarity and continuity in global development teams.' A Cost Hidden in Plain Sight Despite increased investment in agile development practices, companies are still facing major hurdles when it comes to coordinating between internal and external teams. The complexity of modern software systems, combined with geographic and linguistic barriers, often results in remote collaboration breakdowns that go unaddressed until project goals are missed or resources are exhausted. When communication fails, companies often experience cascading effects: shifting requirements, duplicated efforts, missed dependencies, and frequent rework. These outcomes are not just inconvenient; they are the leading indicators of large-scale IT project failure. Tech executives have begun to recognize that even the best tools and methodologies cannot compensate for poor communication structures. 'Effective tech project management requires more than task tracking,' Hernandez explained. 'It demands real-time clarity across diverse teams, especially when leveraging software development outsourcing. The earlier we close those gaps, the greater the chance of delivering successful outcomes.' The Case for Nearshore Outsourcing To solve these communication bottlenecks, ParallelStaff is promoting a nearshore outsourcing model designed specifically to enable stronger collaboration and execution. Unlike offshore development models that operate in distant time zones with greater cultural differences, nearshore teams share similar working hours and business practices, making real-time engagement far more attainable. With development professionals located in Latin America and fluent in English, ParallelStaff's nearshore outsourcing approach facilitates direct collaboration during core business hours. This structure supports daily standups, rapid iterations, and smoother cross-functional integration, which are cornerstones of software development best practices. 'Nearshore teams allow for faster resolution of blockers, more interactive sprint planning, and tighter feedback loops,' said Hernandez. 'This alignment is particularly critical for companies adopting or scaling agile development frameworks.' A Scalable, Communication-First Solution At the heart of ParallelStaff's approach is a focus on pairing technical excellence with communication competence. The company recruits, vets, and places developers based on both their coding expertise and their ability to operate effectively within client workflows and cultures. Rather than offering generalized outsourcing solutions, ParallelStaff tailors its engagements to match the client's organizational structure and project lifecycle. Developers are embedded into existing teams to ensure shared ownership and proactive participation, an approach that enhances accountability and reduces misinterpretations that lead to costly rework. Key benefits of ParallelStaff's model include:• Seamless integration with agile development challenges and workflows• Reduced friction in remote collaboration due to time zone and language alignment• Access to a curated network of experienced software professionals• A flexible model that scales as business needs evolve 'We're seeing that tech leaders don't just want headcount, they want contributors who can communicate, collaborate, and deliver within the context of their strategy,' Hernandez said. 'That's where we focus our energy.' Moving from Risk to Readiness As businesses scale digital operations and embrace hybrid work environments, communication is no longer a soft skill, it's a critical infrastructure component. ParallelStaff's initiative is positioned to help organizations identify risk areas early and implement sustainable solutions that reduce the likelihood of IT project failure. In an industry where delays and inefficiencies can cost millions, aligning development resources through effective communication isn't just a competitive advantage; it's an operational necessity. To assist companies in addressing communication breakdowns and improving project performance, ParallelStaff is offering complimentary strategy calls with its technical team. During these sessions, stakeholders can assess their current development structures, identify potential risks, and explore how a nearshore model can enhance execution and delivery. About ParallelStaff ParallelStaff is a Dallas, Texas–based company that provides nearshore outsourcing and IT staffing solutions for businesses seeking scalable, high-performance development teams. Focusing on English-fluent, culturally aligned professionals, ParallelStaff helps clients improve communication, agility, and execution in complex software Media Contact Company Name: ParallelStaff Contact Person: Miguel Hernandez Email: hello@ Phone: (214) 945 8202 Country: United States Website:

RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives
RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives

Yahoo

time37 minutes ago

  • Yahoo

RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives

LOS ANGELES, June 11, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) ('RadNet'), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today announced that it has entered into Incremental Amendment No. 2 (the 'Second Amendment') to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the 'Existing Credit Agreement' and, as amended by the Second Amendment, the 'Credit Agreement'). Pursuant to the Second Amendment, Barclays Bank PLC, as lender, committed to provide RadNet an incremental term loan in the aggregate principal amount of $100.0 million (the '2025 Incremental Term Loan'), which will be added to and form a part of the existing term loan under the Existing Credit Agreement (the 'Existing Term Loan,' together with the 2025 Incremental Term Loan, the 'Term Loan'). The 2025 Incremental Term Loan will mature on April 18, 2031—coincident with the maturity date of the $868.4 million balance of the Existing Term Loan under the Existing Credit Agreement. Quarterly payments of principal on the Term Loan will be approximately $2.4 million compared to approximately $2.2 million prior to the entry of the Second Amendment. All other terms and covenants of the Credit Agreement (as amended by the Second Amendment) remain unchanged. The proceeds of the 2025 Incremental Term Loan will be used to finance future acquisitions and for other general corporate purposes, providing RadNet with additional flexibility to pursue strategic growth opportunities across its national imaging center network and technology platforms. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, commented, 'We appreciate the continued support of Barclays and our relationship banks and term-loan lenders. This incremental financing increases our capacity to execute on a pipeline of acquisition opportunities while maintaining our conservative capital structure. The proceeds of approximately $100 million adds to the $717 million cash balance as of March 31, 2025, positioning us to advance our growth strategy and create long-term value for our stockholders.'RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 401 owned and/or operated outpatient imaging centers. RadNet's imaging center markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information, visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

National Corporate Housing Releases Annual Corporate Social Responsibility Report Celebrating 25 Years Of Positive Impact
National Corporate Housing Releases Annual Corporate Social Responsibility Report Celebrating 25 Years Of Positive Impact

Yahoo

time44 minutes ago

  • Yahoo

National Corporate Housing Releases Annual Corporate Social Responsibility Report Celebrating 25 Years Of Positive Impact

2025 National Corporate Housing Leadership and Sales Conference GREENWOOD VILLAGE, Colo., June 11, 2025 (GLOBE NEWSWIRE) -- National Corporate Housing has released its annual Corporate Social Responsibility Report that showcases the company's commitment to focusing on people, operating sustainably, and enriching community. 'Corporate social responsibility has been a core part of our mission since Day One, and we are more committed than ever to sustainable growth,' says Tom Atchison, National Corporate Housing CEO and founder. 'Our environmental, social, and governance (ESG) strategy will remain at the heart of our decision-making as we embrace innovation, sustainability, and inclusivity. We are not just preparing for the next 25 years - we are actively shaping them.' That momentum—and National's principle to always do the right thing— drives progress in every business area. As a global leader in customized corporate housing since 1999, National is proud of the gains it's made in: Prioritizing peopleNational champions a diverse, inclusive workplace through initiatives that include a DEI Advisory Council, employee resource groups, and a commitment to pay equity and advancement. Ongoing learning opportunities, tuition reimbursement and well-being benefits create a culture of care and support that helps employees thrive. Increasing sustainability National strives to reduce its carbon footprint and promote sustainable practices. Waste reduction and resource circularity—from buying high-quality durable goods that reduce environmental impact to donating gently used household goods to local nonprofits—helps protect the environment. National also prioritizes partnerships with vendors who are good environmental stewards. In 2026, National will launch an Environmental Awareness Training program for employees to support sustainability goals. National recently helped launch a tool to measure and manage greenhouse gas emissions from energy use in furnished apartments. This free tool is available to all corporate housing providers to boost the industry's environmental stewardship. Community Enrichment From the Angel Tree Holiday Drive that provided gifts for children and families in need to the Haven For Hope partnership that provided hygiene essentials for people experiencing homeless, National actively does good for their communities. Paid volunteer leave for employees, Community Impact Awards that fund employee-chosen nonprofits, and ongoing outreach highlight National's commitment to give back. 'The next 25 years will challenge us to think bigger and act bolder,' says Amber Smith, Head of ESG. 'From climate change and digital transformation to evolving definitions of work and belonging, the future will demand innovation, agility, and an unwavering sense of purpose. Here's to the next 25 years of impact, innovation, and inclusion.' For media inquiries, please contact:Peggy Smith, Chief Innovation Officer, Marketing(720) 392-3990 | psmith@ About National Corporate Housing: At National, we turn complex temporary housing challenges into seamless solutions. As a global leader in customized corporate housing since 1999, we provide personalized, 360-degree services that ensure your employees feel at home, wherever they are in the world. With our extensive network and local expertise, we make the unfamiliar comfortable, delivering exceptional experiences that transform clients into lifelong partners. A photo accompanying this announcement is available at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store